Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extended levodopa release from a subcutaneously implanted polymer matrix in rats.

B A Sabel1, P Dominiak, W Hüaser

  • 1Institute of Medical Psychology, University of Munich Medical School, FRG.

Annals of Neurology
|November 1, 1990
PubMed
Summary

A new slow-release polymer system delivers levodopa continuously for over 225 days in rats, stabilizing treatment for Parkinson's disease patients by eliminating plasma fluctuations.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluating Current Density Modeling of Non-Invasive Eye and Brain Electrical Stimulation Using Phosphene Thresholds.

IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society·2021
Same author

Personality and stress influence vision restoration and recovery in glaucoma and optic neuropathy following alternating current stimulation: implications for personalized neuromodulation and rehabilitation.

The EPMA journal·2020
Same author

[Are Visual Field Defects Reversible? - Visual Rehabilitation with Brains].

Klinische Monatsblatter fur Augenheilkunde·2016
Same author

[The 2-Scale Model of the National Eye Institute Visual Function Questionnaire (NEI-VFQ) to Assess Vision-Related Quality of Life].

Klinische Monatsblatter fur Augenheilkunde·2016
Same author

Repetitive Transcorneal Alternating Current Stimulation Reduces Brain Idling State After Long-term Vision Loss.

Brain stimulation·2015
Same author

Gene-directed enzyme prodrug therapy for localized chemotherapeutics in allograft and xenograft tumor models.

Cancer gene therapy·2014

Area of Science:

  • Neuroscience
  • Biomaterials Science
  • Pharmacology

Background:

  • Oral levodopa therapy for Parkinson's disease often leads to unstable clinical responses due to plasma fluctuations.
  • Managing these fluctuations is crucial for effective Parkinson's disease treatment.

Purpose of the Study:

  • To develop and evaluate a novel slow-release polymer matrix system for continuous levodopa delivery.
  • To assess the potential of this system to overcome the limitations of oral levodopa administration in Parkinson's disease.

Main Methods:

  • A subcutaneous implantation of a slow-release polymer matrix system delivering levodopa was performed in rats.
  • The system was designed for extended-release of levodopa over a prolonged period.

Main Results:

Related Experiment Videos

  • The polymer matrix system successfully delivered levodopa continuously for at least 225 days in the rat model.
  • This sustained delivery eliminated levodopa plasma fluctuations, a key challenge in oral therapy.

Conclusions:

  • Peripheral implantation of levodopa-loaded polymer systems offers a promising new drug delivery technology for Parkinson's disease.
  • This approach could improve patient care by providing stable drug levels and potentially reducing required doses.